Pay in 4 interest-free payments of $7.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
and potential for combination in preclinical models
Smiles: O=C(NCCS(=O)(=O)C1=CC=C(C=N1)C(F)(F)F)C1C=CC(Cl)=CC=1
The expression of Wnt-target genes (AXIN2
PubMed PMID: 27607364
CAN-08-4373
Acalabrutinib - CAS# 1420477-60-6 size:10mg solid and potential for combination inAcalabrutinib, also known as ACP 196, CAS No. 1420477 60 6, is an orally available inhibitor of Brutons tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP 196 inhibits the activity of BTK and prevents the activation of the B cell antigen receptor (BCR) signaling pathway. This prevents both B cell activation and BTK mediated activation of downstream survival pathways. This leads to an inhibition of the growth of